Strides Arcolab unit files first aNDA for injectable drug

By Lisa Kerner

Erie, Pa., April 24 - Strides Arcolab Ltd. said Akorn-Strides, LLC, its joint venture company with Akorn, Inc., has submitted its first abbreviated New Drug Application with the Office of Generic Drugs for a lyophilized injectable drug to treat or prevent infections.

Strides Arcolab is an India-based pharmaceutical company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.